Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2000; 35:1678-1686
© 2000 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mukherjee, D.
Right arrow Articles by Thomas, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mukherjee, D.
Right arrow Articles by Thomas, J. D.

Ten-fold augmentation of endothelial uptake of vascular endothelial growth factor with ultrasound after systemic administration

Debabrata Mukherjee, MD*, James Wong, MD, PhD*, Brian Griffin, MD*, Stephen G. Ellis, MD*, Thomas Porter, MD{dagger}, Subha Sen, PhD* and James D. Thomas, MD, FACC*

* Cardiovascular Imaging Center, Department of Cardiology, The Cleveland Clinic Foundation, Cleveland, Ohio, USA
{dagger} Department of Cardiology, University of Nebraska Medical Center, Omaha, Nebraska, USA



View larger version (22K):

[in a new window]
 
Figure 1 Fluorescent microscopy (100x) revealed marked enhancement of VEGF uptake with US and PESDA. A) reveals minimal endothelial uptake of VEGF after intravenous injection of VEGF without ultrasound. B) reveals minimal fluorescence in the endothelium after injection of buffer solution without VEGF. C) reveals significant deposition of VEGF in the endothelial cells with PESDA and US, using a Langendorff preparation. D) reveals significant deposition of VEGF in the endothelial cells with PESDA and US, after intravenous injection in short-term in vivo experiments. E) reveals significant deposition of VEGF in the endothelial cells with US alone, using a Langendorff preparation. F) reveals significant deposition of VEGF in the endothelial cells with US alone, after intravenous injection in short-term in vivo experiments.

 


View larger version (71K):

[in a new window]
 
Figure 2 Hematoxylin-eosin staining of an adjacent section revealed that the fluorescein-labeled VEGF is predominantly deposited in the endothelium of intramyocardial arterioles (100x).

 


View larger version (147K):

[in a new window]
 
Figure 3 A) shows extensive coagulative necrosis and endothelial disruption with US power of 1.0 W/cm2 without PESDA (4,800x). B) shows endothelial pore formation with US power of 0.8 W/cm2 without PESDA (5,400x). C) (8,000x) shows no significant endothelial changes with US power of 0.6 W/cm2 as compared with control rat heart sections. D) shows a control rat heart section (4,800x).

 


View larger version (132K):

[in a new window]
 
Figure 4 Immunohistochemistry showed marked increase in endothelial cell and smooth muscle cell count (not associated with a vascular lumen) in groups treated with US during administration of VEGF compared with groups treated with VEGF alone. A) shows endothelial cells as shown by vWF staining in a rat heart from an animal treated with VEGF alone and B) shows endothelial cells in a rat heart treated with VEGF + US. C) shows smooth muscle cells in a rat heart from an animal treated with VEGF alone and D) shows a rat heart from an animal treated with VEGF + US. Positively stained cells were counted at 200x.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement